Literature DB >> 6704288

Suppression of plasma cortisol after oral administration of oxazepam in man.

L F Gram, L Christensen, C B Kristensen, P Kragh-Sorensen.   

Abstract

In seven healthy male subjects plasma cortisol was measured at 20 min intervals from 07.00 to 13.00 h, during a drug free control test and after oral administration of 30 and 60 mg oxazepam. A significant suppression of the plasma cortisol levels for about 2 h after 30 mg oxazepam, and for about 3 h after 60 mg oxazepam was observed. The suppression wore off before the oxazepam plasma concentration started to decline significantly.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704288      PMCID: PMC1463316          DOI: 10.1111/j.1365-2125.1984.tb02335.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  The effects of diazepam on sleep, and on the nocturnal release of growth hormone, prolactin, ACTH and cortisol.

Authors:  W P Tormey; C Dolphin; A S Darragh
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

2.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

Review 3.  GABAergic control of anterior pituitary hormone secretion.

Authors:  G Racagni; J A Apud; D Cocchi; V Locatelli; E E Muller
Journal:  Life Sci       Date:  1982-08-30       Impact factor: 5.037

4.  Overdosage of antidepressants: clinical and pharmacokinetic aspects.

Authors:  O L Pedersen; L F Gram; C B Kristensen; M Møller; P Thayssen; M Bjerre; P Kragh-SøRensen; N A Klitgaard; E Sindrup; P Hole; M Brinklø
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Biological substrates of anxiety: benzodiazepine receptors and endogenous ligands.

Authors:  S M Paul; P J Marangos; P Skolnick; F K Goodwin
Journal:  Encephale       Date:  1982       Impact factor: 1.291

6.  Relationship between plasma corticosterone and adrenal epinephrine after diazepam treatment in rats.

Authors:  G Chabot; Y Brissette; A L Gascon
Journal:  Can J Physiol Pharmacol       Date:  1982-05       Impact factor: 2.273

7.  Afternoon plasma cortisol in depressed patients: a measure of diagnosis or severity?

Authors:  L Christensen; C B Kristensen; L F Gram; P Christensen; O L Pedersen; P Kragh-Sørensen
Journal:  Life Sci       Date:  1983-02-07       Impact factor: 5.037

  7 in total
  5 in total

1.  Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.

Authors:  E D Risby; J K Hsiao; R N Golden; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder.

Authors:  Nunzio Pomara; Lisa M Willoughby; John J Sidtis; Thomas B Cooper; David J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

3.  Inhibitory effect of diazepam on the activity of the hypothalamic-pituitary-adrenal axis in female rats.

Authors:  N Pivac; D Pericić
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Benzodiazepine-induced sedation and cortisol suppression. A placebo-controlled comparison of oxazepam and nitrazepam in healthy male volunteers.

Authors:  P Christensen; A Lolk; L F Gram; P Kragh-Sørensen
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124].

Authors:  Hugues Chevassus; Isabelle Mourand; Nathalie Molinier; Bruno Lacarelle; Jean-Frédéric Brun; Pierre Petit
Journal:  BMC Clin Pharmacol       Date:  2004-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.